BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 754784)

  • 21. [Lidoflazine in angina pectoris].
    Schlesinger P; Benchimol AB
    Arq Bras Cardiol; 1972 Oct; 25(5):397-403. PubMed ID: 4651962
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardio-selective beta-adrenergic inhibition by practolol in angina pectoris.
    Frick MH; Katila M
    Fortn Rev Chic Dent Soc; 1970 Sep; 60(5):96-101. PubMed ID: 4393719
    [No Abstract]   [Full Text] [Related]  

  • 23. A new beta receptor blocking agent LB-46 in angina pectoris. (A double blind clinical trial).
    Srivastava BN; Jain PC; Vyas GP
    Indian Heart J; 1972 Jun; 24():Suppl 1:203-4. PubMed ID: 4581428
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of coronary disease patients with Verapamil (Isoptin)].
    Buttolo R; Nardoni A
    Minerva Cardioangiol; 1972 Jan; 20(1):7-21. PubMed ID: 4258309
    [No Abstract]   [Full Text] [Related]  

  • 25. [Trial of labetalol in effort angina pectoris].
    Broustet JP; Cherrier JF; Pic A
    Ann Cardiol Angeiol (Paris); 1985 Mar; 34(3):171-6. PubMed ID: 4004091
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of nifedipine on the course of unstable angina: experience with 23 patients].
    Díaz R; Corbalán R; Marchant E; Casanegra P
    Rev Med Chil; 1983 Feb; 111(2):153-8. PubMed ID: 6648091
    [No Abstract]   [Full Text] [Related]  

  • 27. Perhexilene maleate in treatment of angina pectoris.
    Lyon LJ; Nevins MA; Risch S; Henry S
    Lancet; 1971 Jun; 1(7712):1272-4. PubMed ID: 4104721
    [No Abstract]   [Full Text] [Related]  

  • 28. [Mixed anginas: therapeutic implications].
    Pereira WI; Maseri A
    Arq Bras Cardiol; 1992 Feb; 58(2):87-9. PubMed ID: 1364031
    [No Abstract]   [Full Text] [Related]  

  • 29. [Value of transdermal nitroglycerin in the treatment of patients with stable angina pectoris and its effect on selected hemodynamic parameters].
    Trojnar R; Rymar B; Wysokiński A; Markiewicz M; Wójcik J
    Wiad Lek; 1988 Aug; 41(15):977-83. PubMed ID: 3149817
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapy of angina pectoris with propranolol and long-acting nitrates.
    Goldbarg AN; Morgan JF; Butterfield TK; Nemickas R; Bermudez GA
    Circulation; 1969 Dec; 40(6):847-53. PubMed ID: 4990005
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of the administration of the drug association: hydergine-thioridazine (HM 51), in the treatment of coronary angina].
    Martelli A; Melilla GN
    G Clin Med; 1968 Mar; 49(3):310-43. PubMed ID: 4985903
    [No Abstract]   [Full Text] [Related]  

  • 32. Separate and combined effects of pindolol and isosorbide dinitrate in standardized exercise tests of patients with angina pectoris.
    Zetterquist S; Furberg C; Ringqvist I; Söderholm B
    Curr Ther Res Clin Exp; 1975 Feb; 17(2):139-48. PubMed ID: 803427
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.
    Levy JV
    J Clin Pharmacol New Drugs; 1971; 11(4):249-60. PubMed ID: 4397374
    [No Abstract]   [Full Text] [Related]  

  • 34. The therapeutic effect of L-carnitine in patients with exercise-induced stable angina: a controlled study.
    Cacciatore L; Cerio R; Ciarimboli M; Cocozza M; Coto V; D'Alessandro A; D'Alessandro L; Grattarola G; Imparato L; Lingetti M
    Drugs Exp Clin Res; 1991; 17(4):225-35. PubMed ID: 1794297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sotalol in the treatment of angina pectoris. A double-blind cross-over study.
    Kentala E; Pyörälä K; Frick MH
    Ann Clin Res; 1974 Oct; 6(5):253-7. PubMed ID: 4614692
    [No Abstract]   [Full Text] [Related]  

  • 36. Once-daily treatment of stable angina pectoris.
    Howe A
    Practitioner; 1982 Sep; 226(1371):1621-4. PubMed ID: 6815627
    [No Abstract]   [Full Text] [Related]  

  • 37. The pathophysiology of angina pectoris and the effect of lidoflazine.
    Gobel FL; Nordstrom LA; Nelson RR; Wang Y
    Circulation; 1982 Jan; 65(1 Pt 2):I27-32. PubMed ID: 7030519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacologic profile of a new non-competitive antiadrenergic agent with an anti-angina potential--a derivative of amiodarone].
    Charlier R; Delaunois G; Bauthier J
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):234-52. PubMed ID: 4724571
    [No Abstract]   [Full Text] [Related]  

  • 39. Developmental mechanism of angina pectoris and action of coronary vasodilators.
    Kimura E; Yoshida K; Ushiyama K
    Jpn Heart J; 1967 May; 8(3):219-33. PubMed ID: 5299489
    [No Abstract]   [Full Text] [Related]  

  • 40. [Studies of the severe type of angina pectoris].
    Tawara I
    Nihon Naika Gakkai Zasshi; 1972 Mar; 61(3):262-73. PubMed ID: 5066412
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.